NEXGEL, Inc. (NASDAQ:NXGL) CEO Adam R. Levy Sells 4,000 Shares

NEXGEL, Inc. (NASDAQ:NXGL) CEO Adam R. Levy sold 4,000 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $3.16, for a total value of $12,640.00. Following the completion of the transaction, the chief executive officer now directly owns 374,284 shares of the company’s stock, valued at approximately $1,182,737.44. This trade represents a 1.06 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

NEXGEL Stock Down 1.4 %

NEXGEL stock opened at $2.80 on Friday. The business’s 50-day moving average price is $3.48 and its 200 day moving average price is $3.25. The company has a quick ratio of 0.93, a current ratio of 1.51 and a debt-to-equity ratio of 0.19. The firm has a market cap of $19.01 million, a price-to-earnings ratio of -4.83 and a beta of 0.62. NEXGEL, Inc. has a 52 week low of $1.84 and a 52 week high of $5.10.

Institutional Investors Weigh In On NEXGEL

A number of hedge funds and other institutional investors have recently made changes to their positions in NXGL. Virtu Financial LLC acquired a new position in shares of NEXGEL in the 4th quarter valued at $48,000. IFP Advisors Inc acquired a new stake in NEXGEL during the fourth quarter valued at $49,000. Two Sigma Securities LLC acquired a new position in shares of NEXGEL in the fourth quarter worth about $54,000. Northeast Financial Group Inc. boosted its stake in shares of NEXGEL by 168.8% during the 3rd quarter. Northeast Financial Group Inc. now owns 31,848 shares of the company’s stock worth $82,000 after acquiring an additional 20,000 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of NEXGEL by 5.8% during the 4th quarter. Geode Capital Management LLC now owns 60,142 shares of the company’s stock worth $268,000 after acquiring an additional 3,302 shares in the last quarter. Institutional investors and hedge funds own 2.21% of the company’s stock.

NEXGEL Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.